雷贝拉唑与奥美拉唑治疗反流性食管炎临床比较

Clinical comparison of rabeprazole and omeprazole in the treatment of reflux esophagitis

  • 摘要: 目的:比较雷贝拉唑与奥美拉唑治疗反流性食管炎(RE)的临床疗效。方法将146例 RE 患者随机分为 A 组与B 组,A 组给予雷贝拉唑,B 组给予奥美拉唑,2组患者均联合同剂量西沙必利治疗。比较2组患者治疗8周后的临床疗效与不良反应发生情况。结果 A 组治疗4周后内镜下治愈率及24 h 的 PH<4的反流次数和时间显著优于 B 组(P <0.05),8周后2组内镜下治愈率及24 h 的 PH<4的反流次数和时间无显著差异(P >0.05)。2组药物治疗后与治疗前比较,症状积分均显著下降(P <0.01)。治疗8周后2组间症状积分无显著差异(P >0.05)。结论雷贝拉唑和奥美拉唑治疗反流性食管炎均可获得良好疗效,且安全性高,但雷贝拉唑具有起效快和疗效稳定的优势。

     

    Abstract: Objective To compare the clinical efficacy of rabeprazole and omeprazole (OME)in the treatment of reflux esophagitis (RE).Methods A total of 146 patients with RE were randomly divided into group A treated with rabeprazole and group B with OME,on the basis of same-dosage cisapride.Clinical efficacy and adverse responses between two groups were com-pared after 8-week treatment.Results Group A was evidently better than group B in recovery rate under endoscope after 4-week treatment and reflux times and duration of PH<4 after 24-h treat-ment (P <0.05),but there were no significant differences between above indexes after 8-week treatment (P >0.05).And symptom score reduced markedly after medicine treatment than treat-ment before (P <0.01),but there was no significant difference between two groups after 8-week treatment (P >0.05).Conclusion Rabeprazole and OME both have certain efficacy in treating RE with high safety,but rabeprazole has more advantages in rapid onset and stable efficacy.

     

/

返回文章
返回